VEGFA and neoplasm: Suggested predictive biomarkers for anti-angiogenic treatment include intratumoural and plasma VEGF-A levels, tumour imaging, histopathological growth patterns, pro-inflammatory cytokines, soluble VEGF receptors, gene signatures, and polymorphisms in the VEGF-A pathway genes.